The RESELECT clinical trial will test a number of new treatments for relapsed acquired aplastic anaemia or Bone Marrow Failure Syndrome (BMFS) in younger Australians.
Maddie Riewoldt's Vision will receive the grant from the Emerging Priorities and Consumer Driven Research initiative. This initiative is part of the Medical Research Future Fund.
See the media release for more information on this trial.
/Media Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
